Walid Abi-Saab sold $67k of QURE
Chief Medical Officer at uniQure N.V.. 1,434 shares at an average of $46.86, traded Jun 26, 2026, filed Jun 30, 2026.
Score components
- +15RoleOfficer
- +8Trade size$67k at market
- 0Share of holdings soldSold 0.8% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000904454-26-000387, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | SOpen-market sale Ordinary Shares | -1,434 | $46.86 | $67k | 168,235 | Jun 30, 2026 |
Related signals
Other insiders at uniQure N.V. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | uniQure N.V. | Matthew C Kapusta CEO, Managing Director | $952k 21,082 shares | -4% | |
| 25Weak | uniQure N.V. | Walid Abi-Saab Chief Medical Officer | $1.4M 30,000 shares | -17% | |
| 40Moderate | uniQure N.V. | Jack Kaye director | $983k 21,167 shares | -70% | |
| 30Weak | uniQure N.V. | Matthew C Kapusta CEO, Managing Director | $1.8M 35,412 shares | -7% | |
| 18Weak | uniQure N.V. | Madhavan Balachandran director | $526k 11,685 shares | -21% | |
| 40Moderate | uniQure N.V. | Matthew C Kapusta CEO, Managing Director | $9.4M 206,100 shares | -28% | |
| 13Weak | uniQure N.V. | Jack Kaye director | $225k 5,295 shares | -17% | |
| 14Weak | uniQure N.V. | Madhavan Balachandran director | $279k 10,000 shares | -19% | |
| 41Moderate | uniQure N.V. | Jeannette Potts Chief Legal Officer | $145k 5,237 shares | -4% | |
| 37Weak | uniQure N.V. | Madhavan Balachandran director | $54k 1,993 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.